Global Recombinant Carboxypeptidase B Market Growth 2025-2031

The global Recombinant Carboxypeptidase B market size is predicted to grow from US$ 547 million in 2025 to US$ 956 million in 2031; it is expected to grow at a CAGR of 9.8% from 2025 to 2031.

Recombinant carboxypeptidase B is an enzyme obtained through genetic engineering technology. The gene of recombinant carboxypeptidase B usually comes from organisms in nature, such as Escherichia coli or Pichia pastoris. Through cloning, expression and purification, the recombinant carboxypeptidase B is separated and purified from recombinant Pichia pastoris or Escherichia coli, and then freeze-dried to obtain the lyophilized powder of recombinant carboxypeptidase B.

Recombinant carboxypeptidase B belongs to the metallocarboxypeptidase family, and each molecule contains one Zn atom. It has the ability to specifically hydrolyze the amino end of the C-terminal basic amino acids of proteins (such as lysine, arginine, and histidine). This characteristic makes it have a wide range of application potential in protein sequence analysis, modification, and peptide synthesis.

The activity of recombinant CPB is inhibited by typical metal chelators such as EDTA, and Cu²⁺ and Hg²⁺.

Metal ions such as Zn²⁺ and Mn²⁺ can increase the enzyme activity to varying degrees. The optimal pH of CPB is 8.0. Acidic or alkaline conditions will cause a decrease in activity. When the pH is close to 5.0, the activity is close to zero, and when the pH>12.0, the activity is completely lost. Within a certain temperature range (<60°C), the activity of CPB increases with increasing temperature.

With the continuous development and optimization of genetic engineering technology, the production efficiency and purity of recombinant carboxypeptidase B have been significantly improved, reducing production costs and enhancing market competitiveness. The introduction of new technologies, such as enzyme engineering and fermentation engineering, has further promoted the innovation of the production process of recombinant carboxypeptidase B and improved the yield and quality.

Recombinant carboxypeptidase B has a wide range of applications in biomedicine, scientific research, industrial production and other fields. With the continuous development of these fields, the demand for recombinant carboxypeptidase B is also growing continuously. Especially in the field of biomedicine, recombinant carboxypeptidase B plays an important role in the production of biological drugs such as insulin and antibodies. With the continuous expansion of the biological drug market, its demand will also increase further.

The government's support policies and capital investment in the biopharmaceutical industry have provided strong support for the research and development and production of recombinant carboxypeptidase B. The increase in research and development investment by scientific research institutions and enterprises has promoted the continuous innovation and upgrading of recombinant carboxypeptidase B related technologies.

With the aging of the global population and the improvement of health awareness, the demand for biopharmaceutical products continues to increase, driving the growth of the recombinant carboxypeptidase B market. In addition, the application of recombinant carboxypeptidase B in industrial fields such as food and cosmetics has gradually expanded, further promoting the expansion of the market.

LP Information, Inc. (LPI) ' newest research report, the “Recombinant Carboxypeptidase B Industry Forecast” looks at past sales and reviews total world Recombinant Carboxypeptidase B sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Carboxypeptidase B sales for 2025 through 2031. With Recombinant Carboxypeptidase B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Carboxypeptidase B industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Carboxypeptidase B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Carboxypeptidase B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Carboxypeptidase B market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Carboxypeptidase B and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Carboxypeptidase B.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Carboxypeptidase B market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
＞90%
＞95%
Others

Segmentation by Application:
Functional Studies
SDS-PAGE
HPLC
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
PeproTech
Prospec Bio
BPS Bioscience
Shanghai Yaxin Biotechnology Co., Ltd.
R&D Systems
RayBiotech
Abcam
Advent Bio
Innovative Researc
enQuire BioReagents
Lonza Bioscience
Boster Bio
ProSci

Key Questions Addressed in this Report

What is the 10-year outlook for the global Recombinant Carboxypeptidase B market?

What factors are driving Recombinant Carboxypeptidase B market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Recombinant Carboxypeptidase B market opportunities vary by end market size?

How does Recombinant Carboxypeptidase B break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.